Proarrhythmia associated with cisapride in children

Pediatrics

Volumn 101, Issue 6, 1998, Pages 1053-1056

  Hill, Sharon Laneau ^a   Evangelista, Juli Anne K ^a   Pizzi, Anne Marie ^a   Mobassaleh, Munir ^a   Fulton, David R ^a   Berul, Charles I ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Arrhythmia; Cisapride; QT interval; Repolarization

Indexed keywords

CISAPRIDE; MACROLIDE; OMEPRAZOLE; PROKINETIC AGENT; RANITIDINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG EFFECT; ELECTROCARDIOGRAM; GASTROESOPHAGEAL REFLUX; HEART ARRHYTHMIA; HEART REPOLARIZATION; HEART VENTRICLE TACHYCARDIA; HUMAN; INFANT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QT INTERVAL; TORSADE DES POINTES;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CISAPRIDE; ELECTROCARDIOGRAPHY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL AGENTS; HUMANS; INFANT; LONG QT SYNDROME; PIPERIDINES; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD;

EID: 0031811044     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.101.6.1053     Document Type: Article

References (21)

1. Janssen Pharmaceutics, Inc. Safety Advisory. February 1995
2. Monahan BP, Ferguson CL, Killeavy ES, Lloyd BK, Troy J, Cantilena LR. Torsades de pointes occurring in association with terfenadine use. JAMA. 1990;264:2788-2790
3. Wiley II JF, Gelber ML, Henretig FM, Wiley CC, Sandhu S, Loiselle J. Clinical and laboratory observations. Cardiotoxic effects of astemizole overdose in children. J Pediatr. 1992;120:799-802
4. Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JC, Cantilena LR. Terfenadine-ketaconazole interaction. JAMA. 1993;269:1513-1518
5. Nattel S, Ranger S, Talajic M, Lemery R, Roy D. Erythromycin-induced long QT syndrome: concordance with quinidine and underlying cellular electrophysiologic mechanism. Am J Med. 1990;89:235-238
6. Kemp JP. Antihistamines - is there anything safe to prescribe? Ann Allergy. 1992;69:276-280
7. Berul CI, Morad M. Regulation of potassium channels by nonsedating antihistamines. Circulation. 1995;91:2220-2225
8. Lewin MB, Bryant RM, Fenrich AL, Grifka RG. Cisapride-induced long QT interval. J Pediatr. 1996;128:279-281
9. Bazett HC. An analysis of the time relationships of the heart. Heart. 1920;7:353-370
10. Berul CI, Sweeten TL, Dubin AM, Shah MJ, Vetter VL. Use of the rate-corrected JT interval for prediction of repolarization abnormalities in children. Am J Cardiol. 1994;74:1254-1257
11. Day CP, Mc Comb JM, Campbell RWF. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J. 1990;63: 342-344
12. Shah MJ, Wieand TS, Rhodes LA, Berul CI, Vetter VL. QT and JT dispersion in children with long QT syndrome. J Cardiovasc Electrophysiol. 1997;8:642-648
13. Romano C, Gemme G, Pongiglione R. Aritmie cardiache rare dell'eta pediatrica. Clin Pediatr. 1963;45:658-683
14. Ward OC. New familial cardiac syndrome in children. J Irish Med Assoc. 1964;54:103-106
15. Drolet B, Khalifa M, Daleau P, Hamelin BA, Turgeon J. Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval. Circulation. 1998;97:204-210
16. Berul CI, Aronovitz MJ, Wang PJ, Mendelsohn ME. In vivo cardiac electrophysiology studies in the mouse. Circulation. 1996;94:2641-2648
17. Olsson S, Edwards IR. Tachycardia during cisapride treatment. Br Med J. 1992;305:748-749
18. Wysowski DK, Bacsanyi J. Cisapride and fatal arrhythmia. N Engl J Med. 1996;335:290-291
19. Farrington E. Cardiac toxicity with cisapride. Pediatr Nurs. 1996;22:256
20. Pettignano R, Chambliss CR, Darsey E, Heard M, Clack R. Cisapride-induced dysrhythmia in a pediatric patient receiving extracorporeal life support. Crit Care Med. 1996;24:1268-1271
21. Bran S, Murray WA, Hirsch IB, Palmer JP. Long QT syndrome during high-dose cisapride. Arch Intern Med. 1995;155:765-768